Rapid human immunodeficiency virus diagnostic test during the intrapartum period in pregnant women who did not receive antenatal care

Journal of the Medical Association of Thailand

Volumn 85, Issue 6, 2002, Pages 703-708

  Chalermchockcharoenkit, Amphan ^a   Roongpisuthipong, Anuwat ^a   Sutchritpongsa, Pravit ^a   Louisirirotchnakul, Suda ^a   Sirimai, Korakot ^a   Wasi, Chantapong ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Prevention of Mother to Child HIV Transmission (PMTCT); Standard HIV Testing; The Determine Rapid Test

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PREGNANCY; PRENATAL CARE; PREVALENCE; THAILAND; VERTICAL TRANSMISSION;

AIDS SERODIAGNOSIS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PREVALENCE; SENSITIVITY AND SPECIFICITY; THAILAND;

EID: 0036623318     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomized controlled trial. Lancet 1999; 353: 773-80.
2. th ed. 2000: 107-18.
3. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal-single dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomized trial. Lancet 1999; 354: 795-802.
4. National Institutes of Health/Office of AIDS Research. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in United States. January 24, 2001.
5. Arai H, Petchclai B, Khupulsup K, Kurimura T, Takeda K. Evaluation of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus. J Clin Microbiol 1999; 37: 367-9.
6. Palmer CJ, Dubon JM, Koenig E, et al. Field evaluation of Determine rapid human immunodeficiency virus diagnostic test in Honduras and the Dominican Republic. J Clin Microbiol 1999; 37: 3698-700.
7. WHO. Revised recommendation for the selection and use of HIV antibody tests. Wkly Epidemiol Rec 1997; 12:81-7.
8. Irwin K, Olivo N, Schable C, et al. Performance characteristic of a rapid HIV antibody assay in a hospital with a high prevalence of HIV infection. Ann Intern Med 1995; 125: 471-5.
9. Kassler WJ Haley C, Jones WK, Gerber A, Kennedy EJ, George JR. Performance of a rapid, on-site human immunodeficiency virus antibody assay in a public health setting. J Clin Microbiol 1995; 33: 2899-902.
10. Kassler WJ. Advances in HIV testing technology and their potential impact on prevention. AIDS Educ Prevent 1997; 9: 27-40.
11. Peckham C, Newell ML. Preventing vertical transmission of HIV infection. N Engl J Med 2000; 343: 1036-7.
12. Hu DJ, Dondero MA, Rayfield JR, et al. The emerging genetic diversity of HIV. JAMA 1996; 275: 210-6.